Foghorn Therapeutics Inc (FHTX)
R&D Expenses
$18.52M
Quarterly · Period ending: · USD
FHTX R&D Expenses
Latest reported$18.52Mperiod ending
Latest reported$18.52Mperiod ending
FHTX Quarterly R&D Expenses ($5.31M → $18.52M)
Quarterly R&D Expenses
High-resolution chart · PNG
FHTX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 18,523,000 | |
| 18,259,000 | |
| 22,946,000 | |
| 20,002,000 | |
| 20,892,000 | |
| 21,626,000 | |
| 20,508,000 | |
| 24,689,000 | |
| 23,797,000 | |
| 25,534,000 | |
| 23,353,000 | |
| 26,251,000 | |
| 29,248,000 | |
| 29,985,000 | |
| 28,208,000 | |
| 26,928,000 | |
| 25,974,000 | |
| 24,508,000 | |
| 22,463,000 | |
| 20,494,000 | |
| 18,642,000 | |
| 18,726,000 | |
| 15,908,000 | |
| 16,113,000 | |
| 13,628,000 | |
| 11,503,000 | |
| 13,520,000 | |
| 11,292,000 | |
| 9,775,000 | |
| 9,775,000 | |
| 5,306,250 | |
| 5,306,250 |